Beranda › Diabetes Tipe 1 › Massachusetts › Boston
Uji klinis Diabetes Tipe 1 di Boston, MA
21 studi untuk Diabetes Tipe 1 mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
App-Based Certified Diabetes Education Therapy (AB-CDE)
Menerima peserta
- Joslin Diabetes Center, Harvard School of Medicine, Boston
Type 1 Diabetes Extension Study
Menerima pesertaStudi observasional
- Joslin Diabetes Center, Boston
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Menerima pesertaFase 1/2
- Joslin Diabetes Center, Boston
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Menerima pesertaFase 2
- Joslin Diabetes Center, Boston
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Menerima pesertaFase 3
- Massachusetts General Hospital, Boston
HLA Demographics Study in Adults With Type 1 Diabetes
Menerima pesertaStudi observasional
- Joslin Diabetes Center, Boston
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Menerima pesertaFase 2
- Harvard Medical School - Joslin Diabetes Center and Joslin Clinical (JDS), Boston
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Menerima pesertaFase 2
- Joslin Diabetes Center, Boston
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Menerima pesertaFase 1
- Joslin Diabetes Center, Boston
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Menerima peserta
- Joslin Diabetes Center, Boston
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Menerima pesertaStudi observasional
- Harvard Medical School, Boston
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Menerima peserta
- Massachusetts General Hospital, Boston
Kidney Precision Medicine Project
Menerima pesertaStudi observasional
- Boston Medical Center, Boston
- Joslin Diabetes Center, Boston
Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
Menerima peserta
- Boston Medical Center, Boston
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Menerima pesertaFase 3
- Joslin Diabetes Center, Boston
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
Menerima peserta
- Boston University, Boston
TrialNet Pathway to Prevention of T1D
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Joslin Diabetes Center, Boston
Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes
Menerima peserta
- Boston Children's Hospital, Boston
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Menerima pesertaSukarelawan sehat diterima
- T1D Exchange, Boston
- T1D Exchange, Boston
PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Joslin Diabetes Center, Boston
The T1D Exchange Registry
Menerima pesertaStudi observasional
- T1D Exchange, Boston
Uji klinis Diabetes Tipe 1 di kota lain
- Aurora, CO23 studi
- Seattle, WA18 studi
- Chicago, IL16 studi
- New Haven, CT15 studi
- New York City, NY15 studi
- Indianapolis, IN14 studi
- San Francisco, CA14 studi
- Miami, FL13 studi
- Gainesville, FL12 studi
- Philadelphia, PA11 studi
- Atlanta, GA11 studi
- Durham, NC10 studi
Studi lain di Boston
- Kanker Payudara111 studi
- Kanker Paru Non-Sel Kecil90 studi
- Kanker (semua jenis)86 studi
- Kanker Kolorektal63 studi
- Kanker Metastatik63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat59 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Gagal Jantung44 studi
- Leukemia Mieloid Akut44 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.